SampleID | Type | Habitat | Year | Sequence type | MNS1 | MAS2 |
---|---|---|---|---|---|---|
S_395.Mbi7 | Skin | Skin | 2010 | 16S V2 | 0.10737 | 5.31218 |
S_395.Mbi8 | Skin | Skin | 2010 | 16S V2 | 0.08862 | 4.52268 |
S_395.Mbi9 | Skin | Skin | 2010 | 16S V2 | 0.11173 | 5.24827 |
S_395.Mbo1 | Oral | Oral | 2010 | 16S V2 | 0.09858 | 0.00000 |
S_395.Mbo10 | Oral | Oral | 2010 | 16S V2 | 0.12077 | 21.82910 |
S_395.Mbo11 | Oral | Oral | 2010 | 16S V2 | 0.10124 | 0.93259 |
S_395.Mbo2 | Oral | Oral | 2010 | 16S V2 | 0.09290 | 2.83336 |
S_395.Mbo4 | Oral | Oral | 2010 | 16S V2 | 0.11118 | 6.47038 |
S_395.Mbo6 | Oral | Oral | 2010 | 16S V2 | 0.11500 | 0.86812 |
S_395.Mbo7 | Oral | Oral | 2010 | 16S V2 | 0.07162 | 10.24950 |
S_395.Mbo8 | Oral | Oral | 2010 | 16S V2 | 0.08801 | 0.87874 |
S_395.Mbo9 | Oral | Oral | 2010 | 16S V2 | 0.10692 | 2.68349 |
S_395.Mvag1 | Urogenital | Vagina | 2010 | 16S V2 | 0.03370 | 2.91476 |
S_395.Mvag10 | Urogenital | Vagina | 2010 | 16S V2 | 0.16456 | 2.61027 |
S_395.Mvag2 | Urogenital | Vagina | 2010 | 16S V2 | 0.01542 | 16.80480 |
S_395.Mvag4 | Urogenital | Vagina | 2010 | 16S V2 | 0.04639 | 25.80350 |
S_395.Mvag6 | Urogenital | Vagina | 2010 | 16S V2 | 0.17919 | 9.47146 |
S_395.Mvag7 | Urogenital | Vagina | 2010 | 16S V2 | 0.20046 | 16.36970 |
S_395.Mvag8 | Urogenital | Vagina | 2010 | 16S V2 | 0.11899 | 18.23090 |
S_395.Mvag9 | Urogenital | Vagina | 2010 | 16S V2 | 0.13379 | 1.78832 |
1MNS (Microbiome Novelty Score): < 0.12: Non-novel; 0.12-0.2: Novel; > 0.2: Very novel; -: NA for samples before 2010
2MAS (Microbiome Attention Score): < 10: Low-attention; ≥ 10: High-attention; -: NA for samples before 2010